Cargando…
Value of radiotherapy in addition to esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma: Analysis of surveillance, epidemiology, and end results database
To determine the value of radiotherapy in addition to esophagectomy for stage II and III TESCC. We searched the Surveillance, Epidemiology, and End Results (SEER) database for all cases of stage II‐III TESCC. Patients were grouped as those receiving pre‐ or postoperative radiotherapy plus esophagect...
Autores principales: | Yu, Jing, Ouyang, Wen, Li, Yi, Hu, Jing, Xu, Yu, Wei, Yongchang, Liao, Zhengkai, Liu, Yu, Zhang, Junhong, Xie, Conghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346254/ https://www.ncbi.nlm.nih.gov/pubmed/30561117 http://dx.doi.org/10.1002/cam4.1731 |
Ejemplares similares
-
Mapping patterns of metastatic lymph nodes for postoperative radiotherapy in thoracic esophageal squamous cell carcinoma: a recommendation for clinical target volume definition
por: Yu, Jing, et al.
Publicado: (2019) -
Value of postoperative radiotherapy for stage IIIa-N2 non-small cell lung cancer: an analysis based on SEER database
por: Yang, Ran, et al.
Publicado: (2022) -
Stereotactic body radiotherapy improves the survival of patients with oligometastatic non‐small cell lung cancer
por: Ouyang, Wen, et al.
Publicado: (2019) -
Postoperative Radiotherapy for Thoracic Esophageal Carcinoma with Upfront R0 Esophagectomy
por: Wang, Yichun, et al.
Publicado: (2020) -
Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?
por: Zou, Bingwen, et al.
Publicado: (2020)